These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 9151709)

  • 1. Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis.
    Zhang X; Brunner T; Carter L; Dutton RW; Rogers P; Bradley L; Sato T; Reed JC; Green D; Swain SL
    J Exp Med; 1997 May; 185(10):1837-49. PubMed ID: 9151709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th1 and Th2 subsets equally undergo Fas-dependent and -independent activation-induced cell death.
    Watanabe N; Arase H; Kurasawa K; Iwamoto I; Kayagaki N; Yagita H; Okumura K; Miyatake S; Saito T
    Eur J Immunol; 1997 Aug; 27(8):1858-64. PubMed ID: 9295019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of susceptibility to Fas-mediated apoptosis of TH1 cells by nonmitogenic anti-CD3epsilon F(ab')2.
    Yu XZ; Anasetti C
    Transplantation; 2000 Jan; 69(1):104-12. PubMed ID: 10653388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granzyme B, a new player in activation-induced cell death, is down-regulated by vasoactive intestinal peptide in Th2 but not Th1 effectors.
    Sharma V; Delgado M; Ganea D
    J Immunol; 2006 Jan; 176(1):97-110. PubMed ID: 16365400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD152 (CTLA-4) determines the unequal resistance of Th1 and Th2 cells against activation-induced cell death by a mechanism requiring PI3 kinase function.
    Pandiyan P; Gärtner D; Soezeri O; Radbruch A; Schulze-Osthoff K; Brunner-Weinzierl MC
    J Exp Med; 2004 Mar; 199(6):831-42. PubMed ID: 15007096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic morphine treatment promotes specific Th2 cytokine production by murine T cells in vitro via a Fas/Fas ligand-dependent mechanism.
    Greeneltch KM; Kelly-Welch AE; Shi Y; Keegan AD
    J Immunol; 2005 Oct; 175(8):4999-5005. PubMed ID: 16210602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of sensitivity of Th1, Th2, and Th17 cells to Fas-mediated apoptosis.
    Fang Y; Yu S; Ellis JS; Sharav T; Braley-Mullen H
    J Leukoc Biol; 2010 Jun; 87(6):1019-28. PubMed ID: 20179154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal expression of TRAIL and CD95L in Th1 and Th2 cells: role of apoptosis in T helper subset differentiation.
    Zhang XR; Zhang LY; Devadas S; Li L; Keegan AD; Shi YF
    Cell Death Differ; 2003 Feb; 10(2):203-10. PubMed ID: 12700648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death.
    Ramsdell F; Seaman MS; Miller RE; Picha KS; Kennedy MK; Lynch DH
    Int Immunol; 1994 Oct; 6(10):1545-53. PubMed ID: 7530039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas/Fas ligand pathway, apoptosis, and clonal anergy involved in systemic acetylcholine receptor T cell epitope tolerance.
    Deng C; Goluszko E; Christadoss P
    J Immunol; 2001 Mar; 166(5):3458-67. PubMed ID: 11207304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of activation-induced cell death in the differentiation of T-helper-cell subsets.
    Roberts AI; Devadas S; Zhang X; Zhang L; Keegan A; Greeneltch K; Solomon J; Wei L; Das J; Sun E; Liu C; Yuan Z; Zhou JN; Shi Y
    Immunol Res; 2003; 28(3):285-93. PubMed ID: 14713720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation and function of the Fas/Fas ligand system in human trophoblast cells.
    Aschkenazi S; Straszewski S; Verwer KM; Foellmer H; Rutherford T; Mor G
    Biol Reprod; 2002 Jun; 66(6):1853-61. PubMed ID: 12021072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired Fas signaling pathway is involved in defective T cell apoptosis in autoimmune murine arthritis.
    Zhang J; Bárdos T; Mikecz K; Finnegan A; Glant TT
    J Immunol; 2001 Apr; 166(8):4981-6. PubMed ID: 11290777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Fas ligand-induced apoptosis by TNF.
    Elzey BD; Griffith TS; Herndon JM; Barreiro R; Tschopp J; Ferguson TA
    J Immunol; 2001 Sep; 167(6):3049-56. PubMed ID: 11544288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons.
    Estaquier J; Idziorek T; Zou W; Emilie D; Farber CM; Bourez JM; Ameisen JC
    J Exp Med; 1995 Dec; 182(6):1759-67. PubMed ID: 7500020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential ability of T cell subsets to undergo activation-induced cell death.
    Varadhachary AS; Perdow SN; Hu C; Ramanarayanan M; Salgame P
    Proc Natl Acad Sci U S A; 1997 May; 94(11):5778-83. PubMed ID: 9159150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation of Fas-mediated cytotoxicity and FasL expression in a cytotoxic CD4+ T-cell clone. Comparative analysis of Fas-mediated cytotoxicity between a T-hybridoma and a T-cell clone.
    Kaneda R; Iwabuchi K; Onoé K
    Immunol Lett; 1997 Jan; 55(1):53-60. PubMed ID: 9093882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular mechanism of FasL-mediated cytotoxicity by CD4+ Th1 clones.
    el-Khatib M; Stanger BZ; Dogan H; Cui H; Ju ST
    Cell Immunol; 1995 Jul; 163(2):237-44. PubMed ID: 7541726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
    Greil R; Egle A; Villunger A
    Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of Fas ligand in Th1 and Th2 cells is regulated by early growth response gene and NF-AT family members.
    Dzialo-Hatton R; Milbrandt J; Hockett RD; Weaver CT
    J Immunol; 2001 Apr; 166(7):4534-42. PubMed ID: 11254710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.